Form 8-K - Current report:
SEC Accession No. 0001213900-25-017089
Filing Date
2025-02-25
Accepted
2025-02-25 16:15:31
Documents
16
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea023200801-8k_180life.htm   iXBRL 8-K 34380
2 MUTUAL SETTLEMENT AND GENERAL RELEASE AGREEMENT DATED FEBRUARY 21, 2025, BETWEEN ea023200801ex10-1_180life.htm EX-10.1 61199
3 VOTING AGREEMENT DATED FEBRUARY 21, 2025, BETWEEN 180 LIFE SCIENCES CORP., DR. M ea023200801ex10-2_180life.htm EX-10.2 30274
  Complete submission text file 0001213900-25-017089.txt   367026

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20250221.xsd EX-101.SCH 3799
5 XBRL DEFINITION FILE atnf-20250221_def.xml EX-101.DEF 26637
6 XBRL LABEL FILE atnf-20250221_lab.xml EX-101.LAB 36680
7 XBRL PRESENTATION FILE atnf-20250221_pre.xml EX-101.PRE 25261
18 EXTRACTED XBRL INSTANCE DOCUMENT ea023200801-8k_180life_htm.xml XML 5824
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 25663419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)